Cellen Life Sciences Limited
12164338
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 19/08/2019
COMPANY DIRECTOR
SWEDISH · UNITED KINGDOM · Age 43
Also on 2 other boards
director · Since 28/10/2022
PHYSICIAN AND HEALTH CARE EXECUTIVE
AMERICAN · FRANCE · Age 66
director · Since 28/12/2022
CONSULTANT
BRITISH · ENGLAND · Age 56
Also on 1 other board
director · Since 13/03/2023
CONSULTANT
BRITISH · ENGLAND · Age 48
Also on 3 other boards
Persons with Significant Control
Former PSCs
Mr Eric Gustaf Bystrom
Ceased 24/08/2019
Dr Benjamin Marie Viaris De Lesegno
Ceased 24/10/2019
CompanyRankvs 15+ SIC 21100 peers42
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/08/2023
Net Worth
£3.1M
Balance sheet strength
Cash
£760
Cash in the bank
Net Current Assets
£3.1M
Working capital
Current Assets
£4.0M
Current Liabilities
£865k
Fixed Assets
£6k
Debtors
£4.0M
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit | Est. Revenue |
|---|---|---|---|
| 2023 | 4.62 | +£2.5M | £10k |
| 2022 | 1.51 | +£37k | £10k |
| 2021 | 1.86 | +£3k | — |
| 2020 | 6.10 | — | — |
Derived from filed accounts. Not audited figures.